top of page
Fonds site Web.png
Tube fonds site.png

We improve the management of chronic diseases
thanks to standardized, clinical-grade gut microbiome analysis

tube à essai 2.png

bringing microbiomics to the clinic

Mental disorders

Diabetes

Liver diseases

Bowel diseases

Cancer

We leverage standardized analytical procedures, high-quality quantitative metagenomics and proprietary AI-based algorithms to bring robust and reproducible microbiome analysis to clinicians. Our microbiome analysis software is a CE-marked medical device for in vitro diagnostic offered through medical labs and hospitals.

GMT Science’s mission is to allow physicians to leverage the microbiome in their clinical practice, starting with immuno-oncology.

Robust, reliable and precise microbiome analysis

logo robust 2.png

This offers opportunities to use microbiome-based biomarkers in clinical management.

 

However, clinicians are still in need of reliable solutions to assess the microbiome of their patients for disease prevention, monitoring and prognosis.

logo therapeutics 2.png

Mounting evidence points to changes in the composition and functionality of the gut microbiota in a growing list of medical conditions such as cancer, liver and bowel diseases, diabetes, obesity and mental disorders.

Microbiome science with clinical value

logo technology 2.png

TECHNOLOGY

Francisco Guarner, MD, PhD
Francisco Bio.png
Francisco Photo.png
Fay Betsou, PhD
Fay Bio.png
Fay Photo.png

SCIENTIFIC ADVISORY BOARD

Baptiste Hennecart
Bioinformatics
Baptiste Bio.png
Baptiste Photo.png
Florian Plaza Oñate, PhD
Bioinformatics
Florian Bio.png
Florian Photo.png
Thomas Moncion, PhD
Software development
Thomas M. Bio.png
Thomas M. Photo.png
Vadim Puller, PhD
Bioinformatics
Vadim Bio.png
Vadim Photo.png
Michel Laborde, MD
Medical IT Adviser
Michel Bio.png
Michel Photo.png
Edi Prifti, PhD
Data Science & biostat adviser
Edi Bio.png
Edi Photo.png
Pierre Dechelotte, MD, PhD
Medical Adviser
Pierre Bio.png
Pierre Photo.png
Joël Doré, PhD
Microbiome Science Adviser
Joël Bio.png
Joël Photo.png
Thomas Joder
CBO
Thomas J. Bio.png
Thomas J. Photo.png
Benjamin Duplan
CFO
Benjamin Bio.png
Benjamin Photo.png
Raynald de Lahondès, PhD
CTO
Raynald Bio.png
Raynald Photo.png
Etienne Formstecher, PhD
CEO
Etienne Bio.png
Etienne Photo.png

TEAM

Logo Finger (1).png
Paris Biotech Santé HQ.png
Logo Future 4 Care HQ.png
LOG BPI HQ.png
Logo_Région_Normandie.png
Région_Île-de-France.png

SUPPORT FROM

Logo Pharmabiotic HQ.png
LOGO EMIH HQ.png

MEMBER OF

LOGO INRAE HQ.png
Logo French Gut HQ (1).png
Logo_LFG_unprojet_INRAe_MGP_couleur.png
LOGO INSTITUT GUSTAVE ROUSSY HQ.png
LOGO CHU ROUEN NORMANDIE HQ.png

PARTNERSHIPS

LOGO BIOCODEX HD.png

INVESTORS

NEWS

LAB

75 route de Lyons-la-Forêt, 76000 Rouen

OFFICES

8 Rue Jean Antoine de Baïf, 75013 Paris

CONTACT

bottom of page